Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-oxoacyl-[acyl-carrier-protein] synthase 1 is an essential condensing enzyme in the type II fatty acid synthesis pathway. It catalyzes the addition of malonyl-ACP to an acyl-ACP, elongating the fatty acid chain by two carbons. It functions as a homodimer or tetramer and contains a catalytic cysteine residue. The enzyme is a validated antibacterial drug target; inhibitors of this enzyme block the biosynthesis of long-chain fatty acids, halting bacterial growth. Its homologs are also present in mitochondria, where they participate in fatty acid chain elongation mechanisms[6][7]. If further specificity is needed (e.g., specifying the organism or distinguishing among multiple isoforms such as KAS I, II, or III), consult the relevant UniProt or NCBI entry for sequence, structure, and organism context[6][7].
Inhibition of the condensation step in fatty acid synthesis, blocking cell membrane formation in bacteria[6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-oxoacyl-[acyl-carrier-protein] synthase 1.